Association between interleukin-18 polymorphisms and hepatocellular carcinoma occurrence and clinical progression

Tài liệu liên quan:

• CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: A case-control study

  14 trang 32 0 0

• Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data

  11 trang 27 0 0

• MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells

  13 trang 24 0 0

• Analysis of the expression and prognostic significance of DDK complex in Hepatocarcinoma

  12 trang 23 0 0

• Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma

  17 trang 21 0 0

• Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors

  16 trang 20 0 0

• Circulating tumor cells in hepatocellular carcinoma: A pilot study of detection, enumeration, and next-generation sequencing in cases and controls

  11 trang 20 0 0

• Efficacy and safety analysis of TACE+Donafenib+Toripalimab versus TACE+Sorafenib in the treatment of unresectable hepatocellular carcinoma: A retrospective study

  11 trang 19 0 0

• Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: A systematic review and meta-analysis of randomized controlled trials

  11 trang 18 0 0

• Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma

  19 trang 17 0 0